First non-ATP competitive glycogen synthase kinase 3 beta (GSK-3beta) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples